ECTOPIC INNER FOVEAL LAYER CLASSIFICATION SCHEME PREDICTS VISUAL OUTCOMES AFTER EPIRETINAL MEMBRANE SURGERY

医学 阶段(地层学) 中央凹 视力 视网膜前膜 眼科 外科 玻璃体切除术 视网膜 古生物学 生物
作者
Gerardo González-Saldívar,Alan R. Berger,David T. Wong,Verena R. Juncal,David R. Chow
出处
期刊:Retina-the Journal of Retinal and Vitreous Diseases [Lippincott Williams & Wilkins]
卷期号:40 (4): 710-717 被引量:74
标识
DOI:10.1097/iae.0000000000002486
摘要

Purpose: To evaluate the ectopic inner foveal layer (EIFL) staging scheme as a visual prognostic factor for patients undergoing epiretinal membrane (ERM) surgery. Methods: Retrospective study of 88 pseudophakic patients with diagnosis of idiopathic ERM who underwent ERM surgery with a minimum follow-up of 12 months. Preoperative and postoperative EIFL staging was correlated with the final best-corrected visual acuity (BCVA). As a secondary outcome, evaluation of the proportion of patients achieving final best-corrected visual acuity ≥20/40 in each stage was assessed. Results: Based on the EIFL staging scheme, of 88 pseudophakic eyes analyzed, 24 (27.4%) were diagnosed as Stage 2 ERM, 45 (51.1%) as Stage 3 ERM, and 19 (21.5%) as Stage 4 ERM preoperatively. At the final follow-up visit, 70.8% of eyes with Stage 2 showed an improvement in EIFL staging scheme, while 68% of eyes in Stage 3 and 4 remained the same. The final best-corrected visual acuity significantly improved with all EIFL stages ( P = <0.05). However, earlier stages were associated with better visual outcomes both preoperatively and postoperatively (Stage 2 > Stage 3 > Stage 4 P < 0.001). Final best-corrected visual acuity ≥20/40 was reached in 91.7% of eyes with Stage 2, 42.3% with Stage 3, and 5.2% with Stage 4. Conclusion: The EIFL staging scheme is an easy, fast, and reproducible method to evaluate visual prognosis with ERM surgery. Surgery on Stage 2 ERM results in significantly better visual outcomes and a greater chance of reversibility in anatomical changes.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
脑洞疼应助葛大爷采纳,获得10
3秒前
xxm完成签到 ,获得积分10
3秒前
victory_liu完成签到,获得积分10
3秒前
whitepiece完成签到,获得积分10
7秒前
单纯的小土豆完成签到 ,获得积分10
13秒前
zhaoyaoshi完成签到 ,获得积分10
14秒前
合适靖儿完成签到 ,获得积分10
17秒前
年轻千愁完成签到 ,获得积分10
19秒前
李大白完成签到 ,获得积分0
20秒前
江三村完成签到 ,获得积分0
21秒前
chichenglin完成签到 ,获得积分0
23秒前
迷路的怀蝶完成签到 ,获得积分10
23秒前
24秒前
KYTQQ完成签到 ,获得积分10
27秒前
asdfrfg发布了新的文献求助10
30秒前
scenery0510完成签到,获得积分10
33秒前
大白牛完成签到,获得积分10
33秒前
Yynnn完成签到 ,获得积分10
34秒前
ycd完成签到,获得积分10
35秒前
DJ_Tokyo完成签到,获得积分10
39秒前
科研通AI6应助科研通管家采纳,获得10
40秒前
科研通AI5应助科研通管家采纳,获得10
40秒前
Hao应助科研通管家采纳,获得10
40秒前
搜集达人应助科研通管家采纳,获得10
40秒前
万能图书馆应助科研通管家采纳,获得150
40秒前
Hao应助科研通管家采纳,获得10
40秒前
科研通AI6应助科研通管家采纳,获得30
40秒前
40秒前
萝卜猪发布了新的文献求助10
41秒前
Mian完成签到 ,获得积分10
41秒前
量子星尘发布了新的文献求助10
43秒前
怎么办完成签到 ,获得积分10
43秒前
花flower完成签到 ,获得积分10
44秒前
旅人完成签到 ,获得积分10
44秒前
帅气孤萍完成签到 ,获得积分10
45秒前
巨大的小侠完成签到,获得积分10
50秒前
50秒前
reece完成签到 ,获得积分10
53秒前
广州小肥羊完成签到 ,获得积分10
59秒前
萝卜猪完成签到,获得积分10
1分钟前
高分求助中
Comprehensive Toxicology Fourth Edition 24000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Hydrothermal Circulation and Seawater Chemistry: Links and Feedbacks 1200
Pipeline and riser loss of containment 2001 - 2020 (PARLOC 2020) 1000
World Nuclear Fuel Report: Global Scenarios for Demand and Supply Availability 2025-2040 800
Risankizumab Versus Ustekinumab For Patients with Moderate to Severe Crohn's Disease: Results from the Phase 3B SEQUENCE Study 600
Lloyd's Register of Shipping's Approach to the Control of Incidents of Brittle Fracture in Ship Structures 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 5149878
求助须知:如何正确求助?哪些是违规求助? 4345787
关于积分的说明 13530868
捐赠科研通 4188255
什么是DOI,文献DOI怎么找? 2296746
邀请新用户注册赠送积分活动 1297161
关于科研通互助平台的介绍 1241521